Application of remimazolam combined with propofol in painless endoscopic retrograde cholangiopancreatography
10.12092/j.issn.1009-2501.2023.10.009
- Author:
Hongbo ZHENG
1
;
Wenlong YAO
1
;
Ailin LUO
1
;
Biyun ZHOU
1
Author Information
1. Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Publication Type:Journal Article
- Keywords:
endoscopic retrograde cholangiopancreatography;
monitored anesthesia care complication;
propofol;
remimazolam
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2023;28(10):1154-1160
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To observe and compare the clinical efficacy and safety of remimazolam and propofol alone and in combination in endoscopic retrograde cholangiopancreatography (ERCP) anesthesia. METHODS: A total of 120 patients undergoing elective ERCP were divided into the propofol group (P group), the remimazolam group (R group), and the remimazolam combined with propofol group (RP group) according to a random number table, with 40 patients in each group, and the three groups completed anesthesia according to the designated drug regimen (propofol in group P; remimazolam in group R; and remimazolam combined with propofol in group RP). General information, operation time and awakening time of the patients in the three groups were compared, as well as oxygen saturation (SpO
